Percepción sobre la automedicación con ivermectina por posible exposición a Covid-19 en la población que hace uso de las redes sociales
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Privada de Huancayo Franklin Roosevelt
DOI
Abstract
Este estudio fue evaluar la percepción sobre la automedicación con ivermectina por posible exposición a covid-19 en la población que hace uso de las redes sociales, siendo la metodología, descriptivo, prospectivo y de corte transversal, en una muestra 1089 usuarios que rellenaron el formulario. Resultados, que el nivel de conocimiento fue bajo sobre la automedicación con ivermectina por posible exposición a covid-19 en la población que hace uso de las redes sociales; concluyéndose, que los usuarios que hace uso de las redes sociales y se automedica con ivermectina corresponde al 47.7%
The aim of this study was to evaluate the perception of self-medication with ivermectin for possible exposure to covid-19 in the population that uses social networks. The methodology was descriptive, prospective and cross-sectional, in a sample of 1089 users who filled out the form. Results: the level of knowledge was low on self-medication with ivermectin for possible exposure to covid-19 in the population that uses social networks; concluding that users who use social networks and self-medicate with ivermectin corresponds to 47.7%
The aim of this study was to evaluate the perception of self-medication with ivermectin for possible exposure to covid-19 in the population that uses social networks. The methodology was descriptive, prospective and cross-sectional, in a sample of 1089 users who filled out the form. Results: the level of knowledge was low on self-medication with ivermectin for possible exposure to covid-19 in the population that uses social networks; concluding that users who use social networks and self-medicate with ivermectin corresponds to 47.7%
Description
Keywords
Citation
Vancouver
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess
